Monte Rosa Therapeutics, Inc. logo GLUE - Monte Rosa Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 7
HOLD 2
SELL 0
STRONG
SELL
0
| PRICE TARGET: $31.75 DETAILS
HIGH: $37.00
LOW: $22.00
MEDIAN: $34.00
CONSENSUS: $31.75
UPSIDE: 68.79%
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Revenue
Revenue 4.2 2.8 12.8 23.2 84.9 60.6 9.2 4.7 1.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue 2.0 0 0 0 0 0 0 2.1 1.9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 2.2 2.8 12.8 23.2 84.9 60.6 9.2 2.6 (0.8) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses
R&D Expenses 44.1 42.0 36.7 30.7 32.2 38.9 27.6 26.0 25.1 27.1 28.3 29.1 26.8 24.9 21.3 20.9 17.9 18.1 15.1 14.6 9.3 9.9 5.5 4.9 3.8
SG&A Expenses 10.2 10.5 9.1 8.1 8.7 8.8 8.1 9.3 9.0 7.7 8.7 8.1 7.5 7.6 7.0 6.3 6.4 5.3 4.8 3.5 2.2 2.1 0.9 0.5 0.5
Other Expenses (2.0) 0 0 0 0 0 0 0 0 0 0.0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses 52.2 52.5 45.7 38.7 40.9 47.6 35.7 35.3 34.1 34.9 37.0 37.2 34.3 32.5 28.4 27.2 24.3 23.4 19.9 18.1 11.5 11.9 6.4 5.4 4.3
Operating Income
Operating Income (50.0) (49.7) (33.0) (15.6) 44.0 13.0 (26.5) (32.6) (34.9) (34.9) (37.0) (37.2) (34.3) (32.5) (28.4) (27.2) (24.3) (23.4) (19.9) (18.1) (11.5) (11.9) (6.4) (5.4) (4.3)
Interest Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0
Interest Income 5.6 3.7 2.7 3.1 3.4 2.6 2.9 2.6 2.4 2.4 2.2 2.3 2.4 2.0 1.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0
Profitability
EBITDA (48.0) (47.6) (30.9) (13.4) 46.1 15.1 (24.4) (30.6) (33.0) (33.0) (35.1) (35.8) (33.1) (31.4) (27.3) (26.3) (23.5) (22.6) (19.3) (17.7) (11.2) (11.7) (6.2) (5.3) (4.2)
EBIT (50.0) (49.7) (33.0) (15.6) 44.0 13.0 (26.5) (32.6) (34.9) (34.9) (37.0) (37.2) (34.3) (32.5) (28.4) (27.2) (24.3) (23.4) (19.9) (18.1) (11.5) (11.9) (6.4) (5.4) (4.3)
Income Before Tax (44.5) (46.1) (30.3) (11.1) 47.7 15.6 (23.8) (30.1) (31.9) (33.3) (34.7) (35.0) (32.0) (30.8) (27.3) (26.5) (23.9) (23.4) (19.8) (18.4) (12.3) (19.7) (6.6) (5.4) (4.3)
Income Tax Expense 0.1 0.1 (3.2) 1.2 0.8 2.2 0.1 0.3 0.1 (0.0) 0.2 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income (44.5) (46.1) (27.1) (12.3) 46.9 13.4 (23.9) (30.3) (32.0) (33.3) (34.9) (35.2) (32.0) (30.8) (27.3) (26.5) (23.9) (23.4) (19.8) (18.4) (12.3) (19.7) (6.6) (5.4) (4.3)
Per Share Data
EPS (Basic) -0.68 -0.70 -0.33 -0.15 0.57 0.22 -0.29 -0.43 -0.53 -0.58 -0.70 -0.71 -0.60 -0.59 -0.56 -0.55 -0.51 -0.51 -0.43 -3.63 -0.29 -0.90 -0.30 -0.25 -0.20
EPS (Diluted) -0.68 -0.70 -0.33 -0.15 0.57 0.22 -0.29 -0.43 -0.53 -0.58 -0.70 -0.71 -0.60 -0.59 -0.56 -0.55 -0.51 -0.51 -0.43 -3.63 -0.29 -0.90 -0.30 -0.25 -0.20
Shares Outstanding 65.5 65.5 82.4 82.2 82.1 61.4 82.0 71.2 60.2 56.9 49.8 49.4 49.3 48.9 46.7 46.7 46.6 46.0 46.0 46.0 42.5 21.7 21.7 21.7 21.7
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q1
Current Assets
Cash & Cash Equivalents 159.9 129.9 208.3 69.4 78.5 224.3 125.6 108.8 99.8 128.1 59.1 47.0 51.8 54.9 112.4 103.7 138.3 346.1 367.0 357.1 168.4 41.7 (6.0)
Short-Term Investments 506.4 247.2 182.9 221.2 247.5 147.9 116.6 153.4 93.1 104.3 119.4 156.0 179.9 207.9 159.8 190.5 178.9 0 0 0 0 0 12.0
Net Receivables 4.6 4.6 5.0 2.4 1.4 0.2 0.6 9.8 0.6 0.5 0.3 1.2 2.2 7.7 17.6 0 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 6.7 11.5 5.6 6.5 4.8 5.1 8.4 5.8 5.5 3.3 4.1 3.9 6.7 5.4 1.0 0 0 2.6 0 0 0 0 0
Total Current Assets 677.5 393.2 401.8 299.5 332.3 377.4 251.2 277.9 199.0 236.2 182.9 208.1 240.6 275.9 295.2 297.0 320.4 348.7 370.5 358.3 171.7 43.6 6.0
Non-Current Assets
Property, Plant & Equipment 53.1 50.4 52.7 54.7 55.6 56.3 58.8 61.1 62.5 62.6 64.4 65.7 63.8 61.9 57.9 62.3 20.3 12.3 11.8 8.9 7.7 4.6 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 5.0 0 0 4.9 4.9 0 0 0 0 0 0 0 0 0 5.3 0 0 0 0 0
Other Non-Current Assets 5.8 5.1 5.4 0.4 5.3 5.0 0.2 0.2 5.3 4.9 4.8 4.8 4.7 4.6 4.5 5.7 5.3 0 1.7 1.7 1.2 1.2 (6.0)
Total Non-Current Assets 58.9 55.5 58.0 60.1 60.9 61.3 63.9 66.2 67.7 67.5 69.2 70.5 68.5 66.5 62.4 68.0 25.6 17.7 13.5 10.7 8.9 5.8 (6.0)
Total Assets 736.4 448.7 459.8 359.6 393.2 438.7 315.1 344.1 266.7 303.8 252.1 278.6 309.0 342.4 357.6 365.1 346.0 366.3 384.0 368.9 180.6 49.4 0
Current Liabilities
Account Payables 7.9 3.5 14.5 5.6 6.5 17.2 4.0 6.5 6.8 11.2 5.5 5.3 7.4 7.9 9.8 4.3 4.5 6.6 3.5 7.5 7.3 7.1 0
Short-Term Debt 4.5 4.4 4.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Revenue 33.1 29.6 24.8 18.4 32.6 117.2 18.9 19.6 20.4 17.7 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 25.6 26.7 17.9 8.6 8.3 11.6 15.1 7.6 5.7 9.3 9.1 6.9 7.0 10.6 0 0 0 0.8 0 0 0 19.7 0
Total Current Liabilities 71.0 64.2 61.4 41.9 59.2 156.9 41.6 42.3 41.3 46.6 22.6 19.1 20.5 25.6 21.8 14.8 12.5 16.6 12.7 10.8 9.1 29.3 0
Non-Current Liabilities
Long-Term Debt 34.6 34.8 35.9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 108.9 5.3 116.6 4.6 4.0 3.7 2.8 2.6 2.6 2.7 1.5 1.5 1.5 1.5 2.1 2.1 2.2 2.2 2.0 1.5 232.1 68.8 0
Total Non-Current Liabilities 143.5 151.4 152.6 49.7 58.8 58.9 68.0 77.1 72.9 77.9 45.0 45.9 44.8 45.4 44.7 48.2 7.6 2.2 2.0 1.5 232.1 68.8 0
Total Liabilities 214.5 215.6 214.0 91.5 118.0 215.8 109.6 119.4 114.2 124.5 67.6 65.0 65.3 71.0 66.5 63.0 20.1 18.8 14.7 12.3 241.2 98.1 0
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0
Retained Earnings (521.7) (477.2) (431.1) (404.0) (391.7) (438.6) (452.0) (428.2) (397.9) (365.9) (332.6) (297.8) (262.6) (230.5) (199.8) (172.4) (146.0) (122.0) (98.6) (78.8) (60.4) (48.1) 0
Accumulated Other Comprehensive Income (4.7) (3.8) (3.2) (3.4) (3.3) (3.4) (2.3) (2.7) (2.7) (2.7) (1.5) (1.6) (1.4) (1.8) (2.6) (2.5) (2.1) (2.0) (1.9) (1.4) (0.9) (1.1) (12.1)
Total Stockholders' Equity 521.9 233.1 245.8 268.1 275.2 222.9 205.5 224.7 152.5 179.2 184.5 213.7 243.7 271.4 291.1 302.1 325.9 347.5 369.3 356.7 (60.6) (48.7) 6.8
Total Liabilities & Equity 736.4 448.7 459.8 359.6 393.2 438.7 315.1 344.1 266.7 303.8 252.1 278.6 309.0 342.4 357.6 365.1 346.0 366.3 384.0 368.9 180.6 49.4 6.8
Debt Metrics
Total Debt 39.1 39.2 40.2 41.1 41.9 42.7 43.7 44.4 45.2 46.0 46.4 47.0 46.2 47.0 45.7 48.8 7.0 0 0 0 0 0 0
Net Debt (120.8) (90.7) (168.2) (28.3) (36.7) (181.5) (81.9) (64.5) (54.6) (82.1) (12.7) 0.0 (5.7) (7.9) (66.7) (54.9) (131.3) (346.1) (367.0) (357.1) (168.4) (41.7) 6.0
Metric 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Operating Activities
Net Income (44.5) (46.1) (27.1) (12.3) 46.9 13.4 (23.9) (30.3) (32.0) (33.3) (34.9) (35.2) (32.0) (30.8) (27.3) (26.5) (23.9) (23.4) (19.8) (18.4) (12.3) (19.7) (6.6) (5.4) (4.3)
Depreciation & Amortization 2.0 2.1 2.7 2.1 2.0 2.1 2.7 2.1 1.9 1.8 1.8 1.4 1.2 1.1 2.6 2.2 1.1 0.8 0.6 0.5 0.3 0.2 0.2 0.1 0.1
Stock-Based Compensation 0 4.3 4.4 4.9 5.3 4.5 4.3 4.5 4.9 4.1 4.5 4.2 0 3.3 0 0 0 1.9 2.1 1.0 0.3 0.2 0.0 0.1 0.0
Change in Working Capital 0.1 (3.4) 2.4 (28.7) (98.6) 109.7 9.2 (2.9) (12.9) 57.7 4.4 5.7 4.6 2.1 1.3 1.2 (6.7) 6.6 (0.6) 3.3 (3.0) 3.0 (0.6) 1.0 0.8
Other Non-Cash Items 5.0 0.1 118.0 (0.7) (1.1) (0.7) (13.3) (1.1) (0.1) 1.3 (0.5) (1.4) 2.8 0.4 2.9 2.6 2.1 0.0 0.0 0 1.0 7.7 0.0 0 0
Operating Cash Flow (37.4) (43.0) 100.4 (34.7) (45.5) 128.9 (21.0) (27.8) (38.2) 29.6 (24.7) (25.3) (23.4) (24.0) (20.6) (20.5) (27.4) (14.2) (17.8) (13.6) (13.8) (8.6) (6.9) (4.2) (3.4)
Investing Activities
Capital Expenditure (1.9) (0.8) (0.7) (1.7) (1.6) (0.2) (0.4) (2.0) (1.4) (1.7) (1.7) (6.5) (9.2) (7.3) (1.4) (2.6) (1.6) (3.1) (1.8) (2.7) (2.2) (1.2) (0.9) (1.3) (0.0)
Acquisitions 0 0 0 0 0 0 0 0 0 (0.0) 0 0.1 0 0.0 (0.0) 0 0.1 0.0 0 0 0 0 0 0 0
Purchases of Investments (332.0) (153.7) 0 (19.0) (138.0) (68.0) 0 (74.0) (56.1) (27.5) (7.8) 0 (67.8) (94.4) (59.4) (51.7) (179.0) 0 0 0 0 0 0 0 0
Sales/Maturities of Investments 72.9 89.4 0 46.1 39.4 37.2 0 14.8 67.3 43.5 45.1 25 97.3 47.7 90.3 40 0 0 0 0 0 0 0 0 0
Other Investing Activities 0 0 38.8 0 0 0 38.1 0 0 0.0 0 0 0 (0.0) 0 0 0 0 0.1 0 0 0 0 0 0
Investing Cash Flow (261.0) (65.1) 38.1 25.3 (100.2) (30.9) 37.7 (61.2) 9.9 14.3 35.6 18.6 20.3 (53.9) 29.5 (14.2) (180.5) (3.0) (1.7) (2.7) (2.2) (1.2) (0.9) (1.3) (0.0)
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 (0.2) 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 0 0.3 0 0 47.6 0.0 0 0 0 0 0 0 0.4 0 0 0 0 (1.6) 205.5 0 (0.0) (0.3) (0.2) 0
Financing Cash Flow 328.3 29.6 0.3 0.4 0.0 0.6 0.0 98.0 0.2 25.2 1.1 1.2 0.0 20.4 (0.2) 0.1 0.2 (0.1) 29.5 205.5 142.8 (0.0) 47.7 12.3 0
Cash Position
Net Change in Cash 30.0 (78.5) 138.9 (9.0) (145.7) 98.6 16.8 9.1 (28.3) 69.0 12.0 (5.8) (3.1) (57.5) 9.7 (34.6) (207.8) (21.0) 10.0 188.6 168.4 (9.8) 39.9 6.8 (3.4)
Cash at Beginning 129.9 213.3 74.4 83.4 224.3 130.5 113.7 99.8 128.1 59.1 47.0 52.8 55.9 117.7 103.7 138.3 346.1 367.0 358.8 168.4 0 52.6 12.7 5.9 9.2
Cash at End 159.9 134.8 213.3 74.4 78.5 229.1 130.5 108.8 99.8 128.1 59.1 47.0 52.8 60.2 113.4 103.7 138.3 346.1 368.8 357.1 168.4 42.9 52.6 12.7 5.9
Free Cash Flow (39.2) (43.8) 99.8 (36.4) (47.1) 128.7 (21.4) (29.8) (39.5) 27.9 (26.4) (31.8) (32.6) (31.2) (22.0) (23.1) (29.0) (17.3) (19.5) (16.3) (16.0) (9.8) (7.8) (5.5) (3.4)
Key Metrics 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1
Income Statement
Revenue 4.2 2.8 12.8 23.2 84.9 60.6 9.2 4.7 1.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 2.2 2.8 12.8 23.2 84.9 60.6 9.2 2.6 (0.8) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Income (50.0) (49.7) (33.0) (15.6) 44.0 13.0 (26.5) (32.6) (34.9) (34.9) (37.0) (37.2) (34.3) (32.5) (28.4) (27.2) (24.3) (23.4) (19.9) (18.1) (11.5) (11.9) (6.4) (5.4) (4.3)
Net Income (44.5) (46.1) (27.1) (12.3) 46.9 13.4 (23.9) (30.3) (32.0) (33.3) (34.9) (35.2) (32.0) (30.8) (27.3) (26.5) (23.9) (23.4) (19.8) (18.4) (12.3) (19.7) (6.6) (5.4) (4.3)
EPS (Diluted) -0.68 -0.70 -0.33 -0.15 0.57 0.22 -0.29 -0.43 -0.53 -0.58 -0.70 -0.71 -0.60 -0.59 -0.56 -0.55 -0.51 -0.51 -0.43 -3.63 -0.29 -0.90 -0.30 -0.25 -0.20
Balance Sheet
Cash & Equivalents 159.9 129.9 208.3 69.4 78.5 224.3 125.6 108.8 99.8 128.1 59.1 47.0 51.8 54.9 112.4 103.7 138.3 346.1 367.0 357.1 168.4 41.7 (6.0)
Total Assets 736.4 448.7 459.8 359.6 393.2 438.7 315.1 344.1 266.7 303.8 252.1 278.6 309.0 342.4 357.6 365.1 346.0 366.3 384.0 368.9 180.6 49.4 0
Total Debt 39.1 39.2 40.2 41.1 41.9 42.7 43.7 44.4 45.2 46.0 46.4 47.0 46.2 47.0 45.7 48.8 7.0 0 0 0 0 0 0
Stockholders' Equity 521.9 233.1 245.8 268.1 275.2 222.9 205.5 224.7 152.5 179.2 184.5 213.7 243.7 271.4 291.1 302.1 325.9 347.5 369.3 356.7 (60.6) (48.7) 6.8
Cash Flow
Operating Cash Flow (37.4) (43.0) 100.4 (34.7) (45.5) 128.9 (21.0) (27.8) (38.2) 29.6 (24.7) (25.3) (23.4) (24.0) (20.6) (20.5) (27.4) (14.2) (17.8) (13.6) (13.8) (8.6) (6.9) (4.2) (3.4)
Capital Expenditure (1.9) (0.8) (0.7) (1.7) (1.6) (0.2) (0.4) (2.0) (1.4) (1.7) (1.7) (6.5) (9.2) (7.3) (1.4) (2.6) (1.6) (3.1) (1.8) (2.7) (2.2) (1.2) (0.9) (1.3) (0.0)
Free Cash Flow (39.2) (43.8) 99.8 (36.4) (47.1) 128.7 (21.4) (29.8) (39.5) 27.9 (26.4) (31.8) (32.6) (31.2) (22.0) (23.1) (29.0) (17.3) (19.5) (16.3) (16.0) (9.8) (7.8) (5.5) (3.4)